Miss Tequila
Distinguished Associate
Joined: Dec 19, 2010 10:13:45 GMT -5
Posts: 20,602
|
Post by Miss Tequila on Jan 30, 2021 20:36:33 GMT -5
Is your state limited by supply or logistics? In my state, it was logistics (we still have only given 44% of our on hand vaccines out). Would introducing a third vaccine change the timeline? From what I’ve been reading, it’s having the proper staff available to give the vaccines that is the issue in a lot of places. No clue. It is just my guess at what will happen. Not sure what chain of events happens to get to that choice. That would sway my decision. If I could get the J&J now but have to wait until god knows when foe the other two, I would definitely take J&J. Honestly, that vaccine would give more immunity up front than I have with the Moderna vaccine. It takes 2 weeks from the second shot to get to the 95%, so 6 weeks from the first shot. If the timing would be the same, I would want Pfizer or Moderna.
|
|
|
Post by The Walk of the Penguin Mich on Jan 30, 2021 20:40:05 GMT -5
Us phase 2 people ("the rest") - I suspect we will be given the choice to get the J&J now or wait for one of the other two. Which do I want - 70% now, or 95% in 6 weeks? Hmmmmm...... What is your goal? To avoid getting it all together, or avoiding severe disease? TBH, my biggest fear is severe disease where it has the possibility of doing damage. If a vaccine knocks COVID down to a cold, I can deal with that. The J&J vaccine has an 85% chance of avoiding severe disease. That’s pretty good.
|
|
pulmonarymd
Junior Associate
Joined: Feb 12, 2020 17:40:54 GMT -5
Posts: 7,371
Member is Online
|
Post by pulmonarymd on Jan 30, 2021 21:06:13 GMT -5
J and J makes logistics much easier. We could give it in my office. Manpower issue disappears, scheduling becomes easier as you have fewer people competing for slots, and you can expand distribution sites.
Andifyiu had 100 million doses of this one vs 100 of the others, you get more people vaccine mated and get closer to herd immunity. By decreasing the amount of virus out there, you will decrease your personal risk of infection as well. Multiple variables to consider when making these decisions
|
|
|
Post by The Walk of the Penguin Mich on Jan 31, 2021 11:52:06 GMT -5
I just read this comment about the J&J vaccine. VERY appropriate!
A leading coronavirus vaccine scientist who helped develop Moderna's highly effective vaccine says Johnson & Johnson's new trial results, which tout 72% efficacy for the one-shot vaccine in the US, look "darn good."
"Don't let the perfect get in the way of the good enough," Kizzmekia Corbett, scientific lead for coronavirus vaccines in the Viral Pathogenesis Laboratory at the National Institutes of Health.
|
|
djAdvocate
Member Emeritus
only posting when the mood strikes me.
Joined: Jun 21, 2011 12:33:54 GMT -5
Posts: 75,086
Mini-Profile Background: {"image":"","color":"000307"}
|
Post by djAdvocate on Feb 1, 2021 17:03:02 GMT -5
I've decided I will take whatever vaccine is offered.
|
|
nittanycheme
Established Member
Joined: Aug 8, 2011 14:26:36 GMT -5
Posts: 487
|
Post by nittanycheme on Feb 1, 2021 17:51:08 GMT -5
In a situation where time and other logistics are not a factor, I agree 100%. This is not our current situation. This vaccine does have some advantages now, and also in less urgent times. One dose of J and J offers better protection than one dose of the others. So you are better protected for the 4-6 weeks it takes to be fully vaccinated with the others. Logistically, the storage requirements are a major advantage. I can give the J and J one in my office. I do not kave the storage capability for the others. Scheduling becomes easier, ramp up of vaccination is easier, which leads to faster attainment of herd immunity if we ramp up its supply. The same number of doses of j and j allows us to vaccinate twice as many people, and we don’t have to save any for a second dose, delay a second dose, or worry about people coming back for a second dose. You could also decide to reserve the Pfizer and moderna vaccines for the high risk individuals, and open up vaccination to everyone with j and j at physician offices and pharmacies. This gives all kinds of options to get to herd immunity faster. Given all the variables, when this is all over, it would be a fascinating case study for a game theory class or paper as to which vaccination strategy is most successful. I would also like to point out that the storage conditions make this vaccine much easier to push out to the rest of world. The longer vaccines take to get to places like Africa, Central America, etc. which likely do not and will not be able to effectively store the MNRA vaccines, the less likely variants will occur because the virus will be able to stop spreading quite so rampantly. I also know that JnJ was planning on settling the vaccine at not-for-profit levels at least through the pandemic, which is also a boost to get doses to the rest of the world. I'm not sure what their plans on after that, but realistically if people need to get routinely vaccinated for Covid, one dose would be easier. Also, JnJ does a trial out testing a booster shot (called their Ensemble 2 study; this one was the Ensemble 1). Once again, even if you need 2, you get more efficacy with one than the others, and doctors like PulmonaryMD would still be able to more effectively handle the JnJ one than any of the others. So, it's not just the US, it can help the rest of the world as well. I know that they've signed contracts for production for locations outside the US as well, so that would help production. I am not sure if those are the same locations that are currently making their Ebola vaccine, which is based on the same technology and has been approved by the EU since mid-last year (and used to help stop an Ebola outbreak near the end of last year). "Johnson & Johnson has continued the scaling up of its manufacturing capacity and remains on track to meet its goal of providing one billion doses of a vaccine each year. The Company is committed to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use and anticipates the first batches of a COVID-19 vaccine to be available for emergency use authorization in early 2021, if proven to be safe and effective. " Sep 2020 JnJ vaccine announcement
|
|
NastyWoman
Senior Associate
Joined: Dec 24, 2010 20:50:37 GMT -5
Posts: 14,350
|
Post by NastyWoman on Feb 4, 2021 1:23:02 GMT -5
😁 You just made up my mind: I want Pfizer It's either that or whatever comes first as long as it comes with my (annual) can of Pepsi
|
|